標題: Titlebook: Genomic Applications in Pathology; George Jabboure Netto,Karen L. Kaul Book 2019Latest edition Springer International Publishing AG, part [打印本頁] 作者: 美麗動人 時間: 2025-3-21 17:57
書目名稱Genomic Applications in Pathology影響因子(影響力)
書目名稱Genomic Applications in Pathology影響因子(影響力)學科排名
書目名稱Genomic Applications in Pathology網(wǎng)絡(luò)公開度
書目名稱Genomic Applications in Pathology網(wǎng)絡(luò)公開度學科排名
書目名稱Genomic Applications in Pathology被引頻次
書目名稱Genomic Applications in Pathology被引頻次學科排名
書目名稱Genomic Applications in Pathology年度引用
書目名稱Genomic Applications in Pathology年度引用學科排名
書目名稱Genomic Applications in Pathology讀者反饋
書目名稱Genomic Applications in Pathology讀者反饋學科排名
作者: 可商量 時間: 2025-3-21 20:16
Current Massively Parallel Sequencing Technologies: Platforms and Reporting Considerationsquencing one small (several hundred bp) DNA region at a time, using a specific pair of complementary primers targeted to just that area of interest, the new sequencing platforms utilize a shotgun approach, randomly shearing the entire genome into over 300 million small fragments, sequencing each of 作者: 統(tǒng)治人類 時間: 2025-3-22 01:18
Emerging Next-Generation Sequencing Technologies number variation, inversions, chromosomal rearrangements], epigenomic, and transcriptional. Long read lengths are required to enable efficient genomic assembly and accurate phasing, and the detection method must produce highly accurate base calls to minimize errors and reduce costly iterative seque作者: Preserve 時間: 2025-3-22 08:36 作者: chronicle 時間: 2025-3-22 11:11 作者: 善于 時間: 2025-3-22 14:46
Circulating Tumor Cells: Enrichment and Genomic Applicationsion of CTCs carries great potential as a tool in cancer patient management and prognostication. Numerous clinical trials on early and metastatic cancer are employing CTCs to evaluate the efficacy of systemic therapy. There is also an increasing interest in using CTCs for detailed molecular and cellu作者: 善于 時間: 2025-3-22 20:36 作者: 狂熱文化 時間: 2025-3-23 00:18
Genomic Pathology: Training for New Technologye testing, let alone genomic analysis. Pathologists, given their background in molecular diagnostics and experience directing clinical laboratories, must play a major role in translating genomic technology to patient care. This chapter reviews the significant progress that the pathology community ha作者: 領(lǐng)導權(quán) 時間: 2025-3-23 04:19
Clinical Implementation of Next-Generation Sequencing (NGS) Assaysmolecular diagnostic laboratories for various indications. However, laboratory directors need to be prepared for the numerous challenges associated with the implementation of NGS technologies. These include the need to select an appropriate platform based on the purpose of the test, to recruit appro作者: Glucose 時間: 2025-3-23 06:42 作者: Debility 時間: 2025-3-23 10:00
Patents and Proprietary Assaysuction of novel diagnostic tests. Opponents argue that patents are unnecessary for discovery and that they raise costs, decrease patient access, and harm innovation in the field of molecular pathology. In two recent Supreme Court cases, . and ., the Court ruled that biological correlations and human作者: Endemic 時間: 2025-3-23 14:35 作者: 脊椎動物 時間: 2025-3-23 20:38
Transitioning Discoveries from Cancer Genomics Research Laboratories into Pathology Practiceindings essential for the use of novel classes of targeting therapies. Although there is considerable enthusiasm for the use of the discoveries of cancer genomics for personalized medicine in clinical practice, the number of new classes of biomarkers incorporated into cancer diagnosis and treatment 作者: Ordnance 時間: 2025-3-23 22:31 作者: 高度 時間: 2025-3-24 03:40 作者: ATP861 時間: 2025-3-24 07:09 作者: 欄桿 時間: 2025-3-24 14:38
Zu Puayen Tan,Brian Thurow,Shengxian Shils and tissues and is allowing us to better understand alternative splicing and the functional elements of the genome and to identify single-nucleotide variants and new fusion transcripts in cancer. We also review current and potential clinical applications of RNA-Seq technology in inherited, chronic, neoplastic, and infectious diseases作者: 通便 時間: 2025-3-24 17:39
https://doi.org/10.1007/978-981-10-0033-1ons in human genes and genotype–phenotype relationships and will help facilitate the introduction of large-scale sequencing into clinical practice. The Supreme Court has thereby encouraged the advancement, development, and implementation of personalized medicine.作者: 喊叫 時間: 2025-3-24 20:37
Getting to Grips with Neuronal Diversity,t the computational processing, analysis, and interpretation of NGS results. These efforts have facilitated a broad dissemination of NGS into every facet of biomedical research and into a growing list of clinical diagnostic applications from targeted multigene panels to whole-genome sequencing.作者: Adornment 時間: 2025-3-25 01:03
-driven informatic analysis of exomes or genomes. Improved efficiency of molecular genetic testing, driven by the development and implementation of comprehensive disease-targeted gene panels, is propelling the advancement of genomic medicine.作者: 共同時代 時間: 2025-3-25 03:26
Transcriptome Sequencing (RNA-Seq)ls and tissues and is allowing us to better understand alternative splicing and the functional elements of the genome and to identify single-nucleotide variants and new fusion transcripts in cancer. We also review current and potential clinical applications of RNA-Seq technology in inherited, chronic, neoplastic, and infectious diseases作者: 轎車 時間: 2025-3-25 10:10 作者: 大看臺 時間: 2025-3-25 15:32 作者: 盡管 時間: 2025-3-25 17:43 作者: 兩種語言 時間: 2025-3-25 23:05
Book 2019Latest editionrs. A paradigm shift in pharmacogenomics and in the diagnosis of genetic inherited diseases and infectious diseases is unfolding as the result of implementation of next generation genomic technologies. With rapidly growing knowledge and applications driving this revolution, along with significant te作者: 心神不寧 時間: 2025-3-26 01:31
Practicing Pathology in the?Post-genomic Era: Challenges and Opportunitiestandards, and proficiency programs. Evolving issues include the type, target, and timing of genomic analysis of tumors and regulatory and reimbursement issues. Additionally, educational needs for pathology trainees, practicing pathologists, and clinical colleagues should be addressed.作者: 借喻 時間: 2025-3-26 06:03
Circulating Cell-Free DNA for Molecular Diagnostics and Therapeutic Monitoringequired advances in technology that have only recently become available. In this chapter, we review the history of circulating DNA, technologies for identifying and measuring it, and applications, especially as a cancer biomarker, that promise to emerge as new standards of care for clinical medicine.作者: 能夠支付 時間: 2025-3-26 09:08
Case Study: Gill Plasticity in Larval Fishess. The value of existing concepts of laboratory-developed tests and companion diagnostics will need revision in order to accommodate genomic sequencing assays. This chapter addresses these issues and the notion that, to some extent, these novel technologies will challenge established definitions of disease and the foundations of medical practice.作者: 使習慣于 時間: 2025-3-26 13:13
Application of landscape ecology,r high-throughput sequencing can be applied to single-gene targets in specialized situations. This chapter discusses these applications in minimal residual disease detection, infectious diseases, and HLA typing, among others.作者: palette 時間: 2025-3-26 17:54 作者: 胡言亂語 時間: 2025-3-26 23:59 作者: 離開就切除 時間: 2025-3-27 01:25
Dimensions of Development Theory,nges facing the development of new sequencing technologies. This chapter provides a broad overview of emerging new sequencing technologies including single-molecule and nanopore approaches. Potential applications in nucleic acid analysis which will be enabled by these technological advances are also highlighted.作者: 確定 時間: 2025-3-27 06:53
https://doi.org/10.1007/978-3-642-13153-0r different preparations of biological samples, taking into account advantages and disadvantages of each approach. Furthermore, we discuss the diagnostic and therapeutic efficacy of miRNAs as well as their future roles in personalized medicine, from a technical perspective.作者: extemporaneous 時間: 2025-3-27 13:15 作者: 罐里有戒指 時間: 2025-3-27 14:26 作者: 圓錐體 時間: 2025-3-27 18:56 作者: 競選運動 時間: 2025-3-28 01:50 作者: 吸氣 時間: 2025-3-28 02:26
Clinical Implementation of Next-Generation Sequencing (NGS) Assays clinicians. Guideline documents now exist, and many laboratories have already successfully applied the existing clinical laboratory regulations to this novel category of high-complexity testing. Nevertheless, NGS technologies hold great promise for the future despite some currently perceived barriers to implementation.作者: 值得贊賞 時間: 2025-3-28 08:53
Ethical Issues in Clinical Genetics and Genomicsso do not provide powerful information about many disease-linked variants. It ends by discussing how WGS and other “broad” tests will greatly exacerbate the ethical and legal problems of existing testing methods, particularly with respect to accuracy, conveying results, and confidentiality.作者: RUPT 時間: 2025-3-28 11:38 作者: 拋棄的貨物 時間: 2025-3-28 14:51 作者: arrhythmic 時間: 2025-3-28 20:29 作者: 詼諧 時間: 2025-3-29 01:00 作者: 我沒有強迫 時間: 2025-3-29 03:35 作者: MURKY 時間: 2025-3-29 08:00 作者: dry-eye 時間: 2025-3-29 11:25 作者: perpetual 時間: 2025-3-29 16:04 作者: 發(fā)微光 時間: 2025-3-29 21:49
Recent Fischer: Emotional Development, CTCs has both opened doors to understanding the roles of CTC-associated cells in metastasis as well as raised questions about how to capture and characterize these circulating stromal cells (cStCs). Better characterization of both CTCs and CTC-associated circulating cells should clearly lead to a b作者: ESPY 時間: 2025-3-30 03:03 作者: Colonoscopy 時間: 2025-3-30 04:24
gists and other subspecialized pathologists, general pathologists, pathology and other trainees, oncologists, geneticists and a growing spectrum of other clinicians. ?With periodic updates and a sufficiently ra978-3-319-96830-8作者: 被詛咒的人 時間: 2025-3-30 10:16
Springer International Publishing AG, part of Springer Nature 2019作者: 顯微鏡 時間: 2025-3-30 12:37
https://doi.org/10.1057/9781137286659e testing, let alone genomic analysis. Pathologists, given their background in molecular diagnostics and experience directing clinical laboratories, must play a major role in translating genomic technology to patient care. This chapter reviews the significant progress that the pathology community has made in genomic medicine training.作者: ALB 時間: 2025-3-30 18:52 作者: 輕快來事 時間: 2025-3-30 23:16
https://doi.org/10.1007/978-3-319-96830-8Circulating Tumor Cells; Clinical Genomics; Genomic Medicine; Pharmacogenomics; RNAseq; Sequencing Assays
